BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 24167019)

  • 1. Omalizumab therapy for allergic bronchopulmonary aspergillosis in children with cystic fibrosis: a synthesis of published evidence.
    Tanou K; Zintzaras E; Kaditis AG
    Pediatr Pulmonol; 2014 May; 49(5):503-7. PubMed ID: 24167019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omalizumab in the management of steroid dependent allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis.
    Wong R; Wong M; Robinson PD; Fitzgerald DA
    Paediatr Respir Rev; 2013 Mar; 14(1):22-4. PubMed ID: 23287795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti IgE antibody as treatment of allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis.
    Zicari AM; Celani C; De Castro G; Valerio De Biase R; Duse M
    Eur Rev Med Pharmacol Sci; 2014 Jul; 18(13):1839-41. PubMed ID: 25010610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
    Jat KR; Walia DK; Khairwa A
    Cochrane Database Syst Rev; 2013 Sep; (9):CD010288. PubMed ID: 24043500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
    Jat KR; Walia DK; Khairwa A
    Cochrane Database Syst Rev; 2015 Nov; (11):CD010288. PubMed ID: 26545165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omalizumab: a new treatment option for allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.
    Lehmann S; Pfannenstiel C; Friedrichs F; Kröger K; Wagner N; Tenbrock K
    Ther Adv Respir Dis; 2014 Oct; 8(5):141-9. PubMed ID: 25150265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omalizumab treatment for allergic bronchopulmonary aspergillosis in young patients with cystic fibrosis.
    Perisson C; Destruys L; Grenet D; Bassinet L; Derelle J; Sermet-Gaudelus I; Thumerelle C; Prevotat A; Rosner V; Clement A; Corvol H
    Respir Med; 2017 Dec; 133():12-15. PubMed ID: 29173443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
    Jat KR; Walia DK; Khairwa A
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD010288. PubMed ID: 29551015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case series of omalizumab for allergic bronchopulmonary aspergillosis in cystic fibrosis patients.
    Nové-Josserand R; Grard S; Auzou L; Reix P; Murris-Espin M; Brémont F; Mammar B; Mely L; Hubert D; Durieu I; Burgel PR
    Pediatr Pulmonol; 2017 Feb; 52(2):190-197. PubMed ID: 27717223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omalizumab Treatment for Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis.
    Emiralioglu N; Dogru D; Tugcu GD; Yalcin E; Kiper N; Ozcelik U
    Ann Pharmacother; 2016 Mar; 50(3):188-93. PubMed ID: 26699090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of allergic bronchopulmonary aspergillosis treated with omalizumab.
    Sastre I; Blanco J; Mata H; García F
    J Investig Allergol Clin Immunol; 2012; 22(2):145-7. PubMed ID: 22533243
    [No Abstract]   [Full Text] [Related]  

  • 12. Steroid-sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis.
    Zirbes JM; Milla CE
    Pediatr Pulmonol; 2008 Jun; 43(6):607-10. PubMed ID: 18433040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unexpected decrease in total IgE in a patient with allergic bronchopulmonary aspergillosis treated with omalizumab.
    Wolf BL; Johnson A
    J Allergy Clin Immunol Pract; 2014; 2(1):111-3. PubMed ID: 24565782
    [No Abstract]   [Full Text] [Related]  

  • 14. Omalizumab for treatment of ABPA exacerbations in CF patients.
    Lebecque P; Leonard A; Pilette C
    Pediatr Pulmonol; 2009 May; 44(5):516. PubMed ID: 19382216
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of allergic bronchopulmonary aspergillosis (ABPA) in CF with anti-IgE antibody (omalizumab).
    Kanu A; Patel K
    Pediatr Pulmonol; 2008 Dec; 43(12):1249-51. PubMed ID: 19009619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of omalizumab in the management of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis].
    Delgado Pecellín I; Quintana Gallego E; Pedregal Solano C; Calero Acuña C
    Med Clin (Barc); 2015 Feb; 144(4):190-1. PubMed ID: 25015245
    [No Abstract]   [Full Text] [Related]  

  • 17. Resolution of corticosteroid-induced diabetes in allergic bronchopulmonary aspergillosis with omalizumab therapy: a novel approach.
    Randhawa I; Chin T; Nussbaum E
    J Asthma; 2009 Jun; 46(5):445-7. PubMed ID: 19544162
    [No Abstract]   [Full Text] [Related]  

  • 18. Allergic bronchopulmonary aspergillosis in two patients with cystic fibrosis.
    Anadol D; Ozçelik U; Kiper N; Göçmen A
    Turk J Pediatr; 2000; 42(1):68-71. PubMed ID: 10731875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergic bronchopulmonary aspergillosis in cystic fibrosis: role of atopy and response to itraconazole.
    Nepomuceno IB; Esrig S; Moss RB
    Chest; 1999 Feb; 115(2):364-70. PubMed ID: 10027433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergic bronchopulmonary mycosis complicating cystic fibrosis.
    Knutsen A; Slavin RG
    Semin Respir Infect; 1992 Sep; 7(3):179-92. PubMed ID: 1475542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.